Pfizer Xeljanz's Long-term Dosing Raises Safety Concerns In Ulcerative Colitis
Executive Summary
US FDA's Gastrointestinal Drugs Advisory Committee will weigh proposed indication as agency appears uncertain whether higher dose can be used as long-term therapy.